Mitochondrial Ca2+ Signaling and Bioenergetics in Alzheimer's Disease

Biomedicines. 2022 Nov 24;10(12):3025. doi: 10.3390/biomedicines10123025.

Abstract

Alzheimer's disease (AD) is a hereditary and sporadic neurodegenerative illness defined by the gradual and cumulative loss of neurons in specific brain areas. The processes that cause AD are still under investigation and there are no available therapies to halt it. Current progress puts at the forefront the "calcium (Ca2+) hypothesis" as a key AD pathogenic pathway, impacting neuronal, astrocyte and microglial function. In this review, we focused on mitochondrial Ca2+ alterations in AD, their causes and bioenergetic consequences in neuronal and glial cells, summarizing the possible mechanisms linking detrimental mitochondrial Ca2+ signals to neuronal death in different experimental AD models.

Keywords: AD mouse model; Alzheimer’s disease; astrocyte; bioenergetics; calcium; iPSCs; microglia; mitochondria; neuron.

Publication types

  • Review